Position in TEVA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$996,512
+$143,454 QoQ
Shares Held
29,413
+3.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#338
of 671 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026&PARTNERS holds $18,450,769 across 16 Drug Manufacturers - Specialty & Generic names. TEVA ranks #5 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
67,603 | $4,857,951 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
6,447 | $3,493,178 | |
| 3 | VTRS |
Viatris Inc
|
209,068 | $3,319,999 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
13,769 | $1,527,532 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
29,413 | $996,512 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
29,984 | $737,906 | |
| 7 | PBH |
Prestige Consumer Healthcare Inc.
|
13,127 | $620,513 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
37,853 | $606,783 |
All Filings in TEVA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $996,512 | 29,413 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $853,058 | 28,322 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $708,935 | 22,715 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,122,534 | 55,571 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $894,883 | 53,394 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $462,852 | 30,114 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $672,793 | 30,526 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $600,948 | 33,349 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||